US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms [BNN Bloomberg (Canada)]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: BNN Bloomberg
pandemic influenza as a dangerous strain of bird flu sweeps through the nation's dairy farms, fueling concern about a budding health crisis. The Department of Health and Human Services awarded Moderna $176 million to help pay for late-stage clinical trials that will start in 2025, Dawn O'Connell, assistant secretary for preparedness and response, said in an exclusive interview. The vaccine will be tailored so it can target several influenza strains with pandemic potential, including the family of bird flu viruses currently in circulation. Already one such virus, called H5N1, was detected in 136 cattle herds across 12 states and has infected three farmworkers this year, according to the Centers for Disease Control and Prevention. The nation's top health officials maintain the risk of H5N1 to the general public remains low. No human-to-human transmission has been identified and vaccination isn't currently recommended, O'Connell said. “Our job is to be prepared should that change,”
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine [Yahoo! Finance]Yahoo! Finance
- GSK Secures mRNA Vaccines For Bird Flu, COVID And Seasonal Flu From Struggling Biotech CureVac [Forbes]Forbes
- Moderna's mRNA influenza vaccine receives $176m boost [Yahoo! Finance]Yahoo! Finance
- Cytomegalovirus Infection Therapeutics Research 2024: Comprehensive Insights About 15+ Companies and 20+ Pipeline Drugs Featuring Vir, SpyBiotech, Moderna, VBI, Trellis Bioscience, GSK, & AlloVir [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 6/28/24 - Form 4
- 6/26/24 - Form 144
- 6/21/24 - Form 4
- MRNA's page on the SEC website